Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Allen B. Choi"'
Autor:
Yinwen Cheng, Nicholas Borcherding, Ayomide Ogunsakin, Caitlin D. Lemke-Miltner, Katherine N. Gibson-Corley, Anand Rajan, Allen B. Choi, Wattawan Wongpattaraworakul, Carlos H. F. Chan, Aliasger K. Salem, George J. Weiner, Andrean L. Simons
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The Toll-like receptor 8 (TLR8) agonist VTX-2337 (motolimod) is an anti-cancer immunotherapeutic agent that is believed to augment natural killer (NK) and dendritic cell (DC) activity. The goal of this work is to examine the role of TLR8 exp
Externí odkaz:
https://doaj.org/article/d67bc1582e584855affb057717db487d
Autor:
Patrick Ten Eyck, Henry H. Balfour, J. Brooks Jackson, Danielle Pohl, Allen B. Choi, Kathryn S. Marcus
Publikováno v:
J Am Coll Health
Epstein-Barr virus (EBV) is the cause of infectious mononucleosis, which disproportionately affects university students. This population has the potential to benefit from a prophylactic EBV vaccine trial. Our objectives were to determine EBV infectio
Autor:
Allen B. Choi, Nicholas Borcherding, Andrean L. Simons, George J. Weiner, Wattawan Wongpattaraworakul, Aliasger K. Salem, Caitlin D Lemke-Miltner, Carlos H. F. Chan, Ayomide Ogunsakin, Yinwen Cheng, Anand Rajan, Katherine N. Gibson-Corley
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
The Toll-like receptor 8 (TLR8) agonist VTX-2337 (motolimod) is an anti-cancer immunotherapeutic agent that is believed to augment natural killer (NK) and dendritic cell (DC) activity. The goal of this work is to examine the role of TLR8 expression/a
Autor:
Anand Rajan, Katherine N. Gibson-Corley, Georgina K. Ofori-Amanfo, Patrick Ten Eyck, Allen B. Choi, Steven M. Sperry, Andrean L. Simons, Madelyn Espinosa-Cotton
Publikováno v:
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology
Journal of Oncology
Interleukin-1 alpha (IL-1α) is a pleiotropic cytokine involved in inflammation and immune response and is upregulated in many solid tumors including head and neck squamous cell carcinomas. Although IL-1αexpression is generally associated with poor
Autor:
James R. Howe, Thomas M OʼDorisio, Jessica E. Maxwell, Andrew J Bellizzi, Kendall J. Keck, Allen B. Choi, Joseph S. Dillon
Publikováno v:
Pancreas. 46(9)
Objectives Many patients with small bowel neuroendocrine tumors (SBNETs) have multifocal tumors (MFTs), but the frequency of MFTs has varied widely across SBNET studies. It is also unclear whether patients with MFTs have more advanced disease or wors
Autor:
Guiying Li, Andrew M. Bellizzi, Allen B. Choi, Jessica E. Maxwell, Thomas M. O'Dorisio, Kendall J. Keck, Patrick Breheny, James R. Howe
Tumor grade is an important predictor of survival in gastroenteropancreatic (GEP) neuroendocrine tumors (NETs), as determined by Ki-67 expression and mitotic rate. NETs generally grow indolently, but some cells may acquire traits facilitating metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ac1d8638045b829db90163337f6644
https://europepmc.org/articles/PMC5772651/
https://europepmc.org/articles/PMC5772651/
Autor:
Thomas M. O'Dorisio, Scott K. Sherman, James R. Howe, Andrew M. Bellizzi, Guiying Li, Jessica E. Maxwell, Allen B. Choi
Publikováno v:
Cancer genetics.
CDKN1B , a cyclin-dependent kinase inhibitor associated with G1 arrest, was recently proposed as an important tumor suppressor gene in small bowel neuroendocrine tumors (SBNETs). The rate of frameshift mutations in SBNET primaries are reportedly 7.4%